Ebola vaccine trial targets HIV-Positive adults and teens
⭐️ VACCINE ⭐️
Completed
This study tested an experimental Ebola vaccine (V920) in 251 HIV-infected adults and adolescents to see if it is safe and triggers an immune response. Participants received either the vaccine or a placebo, and researchers monitored side effects and antibody levels. The trial too…
Phase: PHASE2 • Sponsor: Canadian Immunization Research Network • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:10 UTC